AAAAAA

   
Results: 1-11 |
Results: 11
125 Gy or 135 Gy? Response
Authors: Beyer, D Nath, R Butler, W Blasko, J Nag, S Orton, C
Citation: D. Beyer et al., 125 Gy or 135 Gy? Response, INT J RAD O, 49(3), 2001, pp. 898-898
In regard to the American Brachytherapy Society recommendations for (103)Palladium brachytherapy - Response
Authors: Beyer, D Nath, R Butler, W Blasko, J Nag, S Orton, C
Citation: D. Beyer et al., In regard to the American Brachytherapy Society recommendations for (103)Palladium brachytherapy - Response, INT J RAD O, 49(3), 2001, pp. 899-900
The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix
Authors: Nag, S Erickson, B Thomadsen, E Orton, C Demanes, JD Petereit, D
Citation: S. Nag et al., The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix, INT J RAD O, 48(1), 2000, pp. 201-211
American Brachytherapy Society recommendations for clinical implementationof NIST-1999 standards for (103)palladium brachytherapy
Authors: Beyer, D Nath, R Butler, W Merrick, G Blasco, J Nag, S Orton, C
Citation: D. Beyer et al., American Brachytherapy Society recommendations for clinical implementationof NIST-1999 standards for (103)palladium brachytherapy, INT J RAD O, 47(2), 2000, pp. 273-275
Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: Experience over ten years
Authors: Han, I Orton, C Shamsa, F Hart, K Strowbridge, M Deppe, G Porter, A Chuba, PJ
Citation: I. Han et al., Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: Experience over ten years, RADIAT ON I, 7(5), 1999, pp. 289-296
Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines
Authors: Aref, A Mohammad, R Yudelev, M Choudhuri, R Strowbridge, A Orton, C Al-Katib, A
Citation: A. Aref et al., Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines, RADIAT ON I, 7(3), 1999, pp. 158-162
A global strategy for radiotherapy: A WHO consultation
Authors: Porter, A Aref, A Chodounsky, Z Elzawawy, A Manatrakul, N Ngoma, T Orton, C Van't Hooft, E Sikora, K
Citation: A. Porter et al., A global strategy for radiotherapy: A WHO consultation, CL ONCOL-UK, 11(6), 1999, pp. 368-370
Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines
Authors: Aref, A Yudelev, M Mohammad, R Choudhuri, R Orton, C Al-Katib, A
Citation: A. Aref et al., Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines, INT J RAD O, 45(4), 1999, pp. 999-1003
The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States
Authors: Nag, S Orton, C Young, D Erickson, B
Citation: S. Nag et al., The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States, GYNECOL ONC, 73(1), 1999, pp. 111-118
Data in conservation: The missing link in the process
Authors: Suenson-Taylor, K Sully, D Orton, C
Citation: K. Suenson-taylor et al., Data in conservation: The missing link in the process, STUD CONSER, 44(3), 1999, pp. 184-194
Radiotherapy for small-cell lung cancer
Authors: Abadir, R Orton, C
Citation: R. Abadir et C. Orton, Radiotherapy for small-cell lung cancer, N ENG J MED, 340(25), 1999, pp. 2002-2003
Risultati: 1-11 |